Alimentary Pharmacology & Therapeutics

人工智能生成内容（AIGC）工具（如基于大语言模型的ChatGPT等）不能被视为能够在无人类作者指导下发起原创研究，也无法对已发表作品或研究设计负责，且不具备法律地位或持有/转让版权的能力，因此根据COPE关于AI工具的立场声明，这些工具不能履行作者角色，也不能被列为作者。 模型中文摘要

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…

作者署名资格的详细信息请参阅期刊在“编辑政策与伦理考量”部分中的作者署名政策。 模型中文摘要

Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

作者将在投稿过程中被要求提供利益冲突声明；提交作者应与所有合著者沟通，确认其对最终声明的同意。 模型中文摘要

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

期刊期望支持论文结果的数据存档于适当的公共存储库；作者必须提供数据可用性声明，说明共享数据的存在或缺失；当数据已共享时，须在声明中包含所用存储库的链接并引用所共享的数据；如共享数据会损害伦理标准或法律要求，则不要求共享。 模型中文摘要

AP&T expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they h…

该期刊是出版伦理委员会（COPE）成员，并使用iThenticate的CrossCheck软件检测投稿稿件中重叠和相似文本的情况。 模型中文摘要

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley's Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

开放获取适用于希望让非订阅者在发表时获取其文章的初级研究文章作者，或其资助机构要求存档最终版本的作者；作者、资助机构或机构需支付文章出版费（APC）以确保文章通过Wiley Online Library向非订阅者开放，并存入资助机构偏好的存档库。 模型中文摘要

Open Access is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With Open Access, the author, the author's funding agency, or the author's institution pays a fee (Article Publication Charge, or APC) to ensure that the article is made …

所有论文的接受标准是研究的质量和原创性及其对期刊读者群的意义；期刊采用单盲同行评审流程，拥有超过5,500名专家审稿人，论文通常由两名或以上审稿人加一名或多名编辑评审；受邀社论和关于既往论文的致编辑信通常不经同行评审，但会在发表前与原作者分享并给予回复权。 模型中文摘要

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. The journal operates a single-blind peer-review process using a body of over 5,500 expert peer reviewers; papers are normally reviewed by two or more reviewers plus one or more Editors. Invited Editorials and Letters to the Editors about past papers in AP&T are not usu…

期刊可能使用专门软件审查所有论文是否存在剽窃和伪造数据的证据；剽窃可包括以下情形。 模型中文摘要

The Journal may scrutinise all papers for evidence of plagiarism and falsified data using specialised software. Plagiarism can comprise the following:

期刊将考虑评审先前以预印本形式存在的文章；作者也可随时将投稿版本发布至预印本服务器，并被要求用最终发表文章的链接更新任何预发表版本。 模型中文摘要

Alimentary Pharmacology & Therapeutics will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

期刊要求临床试验在公开可访问的数据库中进行前瞻性注册，且报告其结果的论文中应包含临床试验注册号；作者被要求在摘要末尾注明试验注册机构名称和注册号；如试验未注册或为回顾性注册，应说明原因。 模型中文摘要

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…